Axsome Therapeutics to Report First Quarter 2025 Financial Results on May 5

Core Viewpoint - Axsome Therapeutics, Inc. is set to report its financial results for Q1 2025 on May 5, 2025, and will host a conference call to discuss these results and provide a business update [1] Company Overview - Axsome Therapeutics is a biopharmaceutical company focused on treating central nervous system (CNS) disorders, with a portfolio that includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine [3] - The company aims to address significant gaps in care by developing differentiated products with novel mechanisms of action, impacting over 150 million people in the United States [3] Conference Call Details - The conference call will take place at 8:00 a.m. Eastern Time on May 5, 2025, following the financial results announcement [1] - Participants can join the call by dialing (877) 405-1239 for domestic calls or +1 (201) 389-0851 for international calls, with a live webcast available on the company's website [2]